Glycorex Transplantation
1.385 SEK +9.49%Be the first to follow this company
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NGM Main Regulated
GTAB B
Daily low / high price
1.2 / 1.39
SEK
Market cap
102.29M SEK
Turnover
91.15K SEK
Volume
69K
Financial calendar
Interim report
28.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 10.9 % | 7.8 % |
Wendt Investment AB | 7.1 % | 5.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Glycorex Transplantation: Glycosorb® ABO is pushing the boundaries in paediatric blood group incompatible heart transplantation
Glycorex Transplantation: First publication from South Africa and first stem cell transplantation performed in Mexico
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools